在单克隆抗体治疗期间用口服类固醇治疗突破性喘发作的恢复:前性观察性研究 (BOOST) 的协议
Imran Howell1,2, Mahdi Mahdi1,2, Mona Bafadhel3
1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
JMIR research protocols
|June 23, 2023
概括
这项研究调查了单克隆抗体治疗患者的口服皮质类固醇对喘发作的有效性. 它比较了高和低微分呼出氧化 (FeNO) 水平之间的恢复率,以指导未来的治疗策略.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 喘发作显著影响生活质量,并且经常用口服皮质类固醇 (OCS) 治疗,这有副作用.
- 单克隆抗体 (mAbs) 改善了严重喘的治疗,减少了喘发作和OCS的使用,但一些患者仍然经历突破性喘发作.
- 剩余的喘发作可以根据部分呼出的氧化 (FeNO) 水平 (高或低) 分类,这表明不同的炎症概况.
研究的目的:
- 在长期接受mAb治疗的患者中,对高FeNO和低FeNO喘发作进行口服普雷迪尼索隆治疗后的临床恢复进行比较.
- 探索高FeNO和低FeNO喘发作之间的急性口服普雷迪尼索隆治疗炎症反应的差异.
主要方法:
- 这项BOOST研究是一项前性观察性试验,对60名接受喘治疗的成人进行了喘发作.
- 参与者接受急性口服普雷迪尼索隆 (通常的护理).
- 主要结局是28日治疗失败;次要结局包括肺功能和症状评分;探索性结局评估炎症标志物.
主要成果:
- 数据分析和发布计划于2024年.
- 该研究预计将提供基于FeNO水平的治疗反应的见解.
结论:
- 该研究将测试mAb治疗患者的高FeNO和低FeNO喘发作之间的临床和炎症恢复是否不同.
- 结果将为未来的随机试验提供信息,并指导FeNO水平是否应指导突破性喘发作的皮质类固醇治疗.
关键词:
一个成熟的成年人.喘 喘 是一种喘发作是因为喘.炎症反应是一种炎症反应.一个单克隆抗体.这是一种单克隆抗体.口服类固醇口服类固醇普雷迪尼索隆治疗的治疗方法人们的生活质量.类固醇类固醇是什么治疗治疗治疗治疗治疗治疗更多相关视频
09:57Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
12.0K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
357
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
357
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
312
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
312
01:20Asthma: Pathogenesis and Management
458
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
458
01:30Asthma-IV: Nursing Management
3.2K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.2K